CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $194K of Crinetics Pharmaceuticals, Inc.
Sold$193,574
$27.01Price
7,168Shares
−4%Stake
What CRNX did after the filing
- The stock from Wed, Nov 17 close, $27.41
- +3.6%
- S&P 500, same days
- +1.8%
Measured over 30 trading days, to the Dec 31 close.
Traded Mon, Nov 15. Filed Wed, Nov 17, 12:01 PM ET, during the session. Returns use the Nov 17 close and the Dec 31 close. Not investment advice.